Control of Tumorigenesis and Chemoresistance by the DEK Oncogene

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

DEK Proto-Oncogene Expression Interferes With the Normal Epithelial Differentiation Program

American Journal of Pathology
Forensic MedicinePathology
2009English

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

PLoS ONE
Multidisciplinary
2012English

STUB1 Suppress Tumorigenesis and Chemoresistance Through Antagonizing YAP1 Signaling

Cancer Science
Cancer ResearchMedicineOncology
2019English

STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer

Frontiers in Physiology
Physiology
2018English

Transcriptional Control by Myb Oncogene Product.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1992English

The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis

PLoS ONE
Multidisciplinary
2013English

DEK in the Synovium of Patients With Juvenile Idiopathic Arthritis: Characterization of DEK Antibodies and Posttranslational Modification of the DEK Autoantigen

Arthritis & Rheumatism
2011English

Oncogene Amplification During Tumorigenesis of Established Rat Fibroblasts Reversibly Transformed by Activated Human Ras Oncogenes.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1986English

Control of Glioblastoma Tumorigenesis by Feed-Forward Cytokine Signaling

Nature Neuroscience
Neuroscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy